Australia markets closed

Medlab Clinical Limited (MDC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
6.600.00 (0.00%)
At close: 11:59AM AEST

Medlab Clinical Limited

Nova Legal Corporate Lawyers
Level 2 50 Kings Park Road
West Perth, WA 6005
Australia
61 2 8188 0311
https://www.medlab.co

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Sean Michael HallMD & CEO465.87kN/A1971
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Medlab Clinical Limited, a biotechnology company, researches, develops, and sells pharmaceutical products in Australia. The company develops NanoCelle, a drug delivery technology for application to existing and new pharmaceuticals; and researches on the pharmaceutical products in the areas of depression and oncology. It also supplies cannabis-based medicines. The company was incorporated in 2014 and is based in West Perth, Australia.

Corporate governance

Medlab Clinical Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.